(Q46901432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Dorothee Wiewrodt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Georg Nagel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Nadine Dreimüller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Axel Perneczky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bernd Kaina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1391-1399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000822%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

26 December 2019

cites work

1 reference

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

21 January 2018

1 reference

Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents

21 January 2018

1 reference

O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy

21 January 2018

1 reference

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

21 January 2018

1 reference

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents

21 January 2018

1 reference

Variability and regulation of O6-alkylguanine-DNA alkyltransferase

21 January 2018

1 reference

Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer

21 January 2018

1 reference

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study

21 January 2018

1 reference

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments

21 January 2018

1 reference

Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.

21 January 2018

1 reference

p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents

21 January 2018

1 reference

Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas

21 January 2018

1 reference

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

21 January 2018

1 reference

O6-methylguanine-DNA methyltransferase activity in breast and brain tumors.

21 January 2018

1 reference

A simplified assay for O6-methylguanine-DNA methyltransferase activity and its application to human neoplastic and non-neoplastic tissues.

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Apoptosis and proliferation: correlation with p53 in astrocytic tumours.

21 January 2018

1 reference

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

21 January 2018

1 reference

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment

21 January 2018

1 reference

Constitutive expression and inducibility of O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in rat liver cells exhibiting different status of differentiation

21 January 2018

1 reference

Influence of O6-methylguanine-DNA methyltransferase activity on chloroethylnitrosourea chemotherapy in brain tumors

21 January 2018

1 reference

Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.

21 January 2018

1 reference

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

21 January 2018

1 reference

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation

21 January 2018

1 reference

Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma

21 January 2018

1 reference

Expression of p53 and prognosis in children with malignant gliomas.

21 January 2018

1 reference

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

21 January 2018

1 reference

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

21 January 2018

1 reference

One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma

21 January 2018

1 reference

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.

21 January 2018

1 reference

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

21 January 2018

1 reference

Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma

21 January 2018

1 reference